| Current Price | $127.01 | Mkt Cap | $13.2B |
|---|---|---|---|
| Open | $127.77 | P/E Ratio | 647.17 |
| Prev. Close | $127.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $125.08 - $132.83 | Volume | 938,781 |
| 52-Wk Range | $53.40 - $194.75 | Avg. Daily Vol. | 732,482 |
| Current Price | $127.01 | Mkt Cap | $13.2B |
|---|---|---|---|
| Open | $127.77 | P/E Ratio | 647.17 |
| Prev. Close | $127.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $125.08 - $132.83 | Volume | 938,781 |
| 52-Wk Range | $53.40 - $194.75 | Avg. Daily Vol. | 732,482 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NVCR.
Recs
Masakari
(38.17)
Submitted: 3/4/2021 1:41:25 PM :
Start Price:
$136.75
NASDAQ:NVCR Score:
-9.15
This is a medical device company addressing a widespread disease with a proven product that is seeing increasing adoption throughout the medical community. Additionally, their pipeline appears robust and offers significant opportunity to expand their TAM moving forward.
Recs
TreasureCoastJLF
(< 20)
Submitted: 2/19/2021 11:55:04 AM :
Start Price:
$185.97
NASDAQ:NVCR Score:
-29.08
Fighting cancer with physics. You have to go to the website, Novocure.com and read the investor .ppt which has a video. I am a physician and this technology is approved for Glioblastoma & Mesothelioma and is currently in late stage development (phase 3) for Liver Cancer, Ovarian Cancer, and Small Cell Lung Cancer. The pipeline is deep and will tremendously expand the # units in use.
Recs
Frogman452
(< 20)
Submitted: 2/5/2021 3:38:18 PM :
Start Price:
$175.06
NASDAQ:NVCR Score:
-26.01
I am pretty picky about my investments and most pitches I tune out pretty quickly. This is one of the few I can recall being instantly interested in both for its promising financials and more importantly for it's results in treating cancer. Seems almost like a sci-fi future company. Who else can do what they do? Such an easy stock to get behind.
Find the members with the highest scoring picks in NVCR.
stcksrus (97.89) Score: +910.73
The Score Leader is the player with the highest score across all their picks in NVCR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
stcksrus | 97.89 | 7/27/2016 |
|
5Y | $11.69 | +986.48% | +75.75% | +910.73 | 0 Comment |
| synapse | 98.03 | 10/20/2017 |
|
5Y | $18.25 | +595.95% | +48.70% | +547.24 | 0 Comment | |
| findil | 95.36 | 10/23/2017 |
|
5Y | $18.43 | +589.34% | +48.45% | +540.89 | 1 Comment | |
| SuzyP99 | 80.43 | 8/23/2017 |
|
1Y | $18.75 | +577.39% | +56.23% | +521.16 | 1 Comment | |
| lorenzo404 | 42.19 | 1/15/2016 |
|
3W | $17.58 | +622.47% | +104.48% | +517.99 | 0 Comment | |
| kaderoundy | 99.71 |
|
|
NS | $17.98 | +606.40% | +91.87% | +514.53 | 0 Comment | |
|
|
skyrocket29 | 67.58 | 8/22/2017 |
|
1Y | $19.10 | +564.97% | +56.72% | +508.26 | 0 Comment |
| tprooney3 | 96.23 | 7/17/2017 |
|
5Y | $19.25 | +559.79% | +55.51% | +504.29 | 1 Comment | |
| XMFpessen | 97.28 | 12/5/2017 |
|
5Y | $19.95 | +536.80% | +44.45% | +492.35 | 0 Comment | |
| TMFEBCapital | 97.47 |
|
|
3Y | $19.70 | +544.72% | +54.38% | +490.34 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
